Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
3
×
fda
glaxosmithkline
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
congress
crispr
crispr-cas9
duchenne muscular dystrophy
gene editing
incyte
indiana blog main
indiana top stories
jennifer doudna
medicxi
roche
What
bio
crispr
3
×
roundup
alliance
big
biopharma
bosley's
bosley’s
bridge
bristol
bucks
buy
calls
cas
ceo
changing
color
congress
congressional
crime
days
departure
editas
executives
exit
feud
group
growing
guiding
hours
isn’t
katrine
known
kudos
later
leaves
medicine
month
moves
myers’s
Language
unset
Current search:
glaxosmithkline
×
crispr
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More